APPLICATION
ANDA077601
TYPE
ANDA
ORIGINAL APPROVAL
2005-11-15
LATEST ACTION
2023-08-18
ROUTE
ORAL
DOSAGE FORM
SOLUTION
MARKETING STATUS
Discontinued
Products
CITALOPRAM HYDROBROMIDEDiscontinued
CITALOPRAM HYDROBROMIDE EQ 10MG BASE/5ML · SOLUTION · ORAL
Approval history
2023-08-18Labeling · Supplement 9 · standardAP
2021-09-21Labeling · Supplement 8 · standardAP
2021-09-13Labeling · Supplement 7 · standardAP
2017-01-04Labeling · Supplement 6 · standardAP
2015-07-07Labeling · Supplement 5 · standardAP
2014-07-17Labeling · Supplement 4 · standardAP
2014-07-11Labeling · Supplement 3 · standardAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.